Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study.

Parker, William A E

Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study. [electronic resource] - Platelets 2019 - 579-588 p. digital

Publication Type: Journal Article

1369-1635

10.1080/09537104.2018.1478404 doi


Acute Coronary Syndrome--diagnosis
Biomarkers
Blood Platelets--drug effects
Cause of Death
Clopidogrel--therapeutic use
Equilibrative Nucleoside Transporter 1--genetics
Genetic Association Studies
Genetic Predisposition to Disease
Humans
Platelet Aggregation Inhibitors--therapeutic use
Polymorphism, Genetic
Polymorphism, Single Nucleotide
Prognosis
Proportional Hazards Models
Purinergic P2Y Receptor Antagonists--therapeutic use
Ticlopidine--therapeutic use
Treatment Outcome